Celularity Inc (CELU)

Celularity Inc (CELU) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $44.8M; returns 1 day -6.9%, 1 week -21.8%, 1 year -50.9%.

Celularity Inc. is a clinical-stage biotechnology company that utilizes a proprietary technology platform to develop and commercialize regenerative medicine products derived from the postpartum human placenta. The company's business model is bifurcated into high-growth commercial biomaterials and long-term therapeutic R&D.

Groups CELU belongs to

• Biotechnology
• Regenerative Medicine
• Healthcare
• Clinical Stage Biotech
• Life Sciences
• Clinical Stage
• Biopharmaceutical
• Biologics
• Immunotherapy

CELU financial model: income statement, cash flow and balance sheet